Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2071 AL 2085

Genetic Elements at the Alpha-Synuclein Locus

Prahl J, Coetzee GA.

Front Neurosci. 2022 Jul 11;16:889802. doi: 10.3389/fnins.2022.889802. eCollection 2022.

Effectiveness of Augmented Reality for Lower Limb Rehabilitation: A Systematic Review

Chang H, Song Y, Cen X.

Appl Bionics Biomech. 2022 Jul 18;2022:4047845. doi: 10.1155/2022/4047845. eCollection 2022.

Voice Analysis for Neurological Disorder Recognition-A Systematic Review and Perspective on Emerging Trends

Hecker P, Steckhan N, Eyben F, Schuller BW, Arnrich B.

Front Digit Health. 2022 Jul 7;4:842301. doi: 10.3389/fdgth.2022.842301. eCollection 2022.

Nitric Oxide Involvement in Cardiovascular Dysfunctions of Parkinson Disease

Martins-Pinge MC, de Jager L, de Campos BH, Bezerra LO, Turini PG, Pinge-Filho P.

Front Pharmacol. 2022 Jul 11;13:898797. doi: 10.3389/fphar.2022.898797. eCollection 2022.

Review: Subjective Time Perception, Dopamine Signaling, and Parkinsonian Slowness

Miyawaki EK.

Front Neurol. 2022 Jul 8;13:927160. doi: 10.3389/fneur.2022.927160. eCollection 2022.

A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease

Stocchi F, Peckham EL, De Pandis MF, Sciarappa K, Kleiman R, Agbo F, Olanow CW, Blum D, Navia B.

Clin Pharmacol Drug Dev. 2022 Sep;11(9):1068-1077. doi: 10.1002/cpdd.1147. Epub 2022 Jul 28.

Influence of heavy metals in Parkinson's disease: an overview

Vellingiri B, Suriyanarayanan A, Abraham KS, Venkatesan D, Iyer M, Raj N, Gopalakrishnan AV.

J Neurol. 2022 Nov;269(11):5798-5811. doi: 10.1007/s00415-022-11282-w. Epub 2022 Jul 28.

Neuroprotective effect of geraniol on neurological disorders: a review article

Bagheri S, Salehi I, Ramezani-Aliakbari F, Kourosh-Arami M, Komaki A.

Mol Biol Rep. 2022 Nov;49(11):10865-10874. doi: 10.1007/s11033-022-07755-w. Epub 2022 Jul 28.

Does a rare mutation in PTPRA contribute to the development of Parkinson's disease in an Australian multi-incident family?

Hill MA, Bentley SR, Walker TL, Mellick GD, Wood SA, Sykes AM.

PLoS One. 2022 Jul 28;17(7):e0271499. doi: 10.1371/journal.pone.0271499. eCollection 2022.

A molecular dialogue between local translation and mitochondria: powering mitophagy in axons

Soumbasis A, Eldeeb MA.

Mol Biol Rep. 2022 Sep;49(9):9013-9016. doi: 10.1007/s11033-022-07708-3. Epub 2022 Jul 28.

Early differentiation of neurodegenerative diseases using the novel QSM technique: what is the biomarker of each disorder?

Nikparast F, Ganji Z, Zare H.

BMC Neurosci. 2022 Jul 28;23(1):48. doi: 10.1186/s12868-022-00725-9.

The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment

Heris RM, Shirvaliloo M, Abbaspour-Aghdam S, Hazrati A, Shariati A, Youshanlouei HR, Niaragh FJ, Valizadeh H, Ahmadi M.

Stem Cell Res Ther. 2022 Jul 28;13(1):371. doi: 10.1186/s13287-022-03050-4.

Transcranial Current Stimulation as a Tool of Neuromodulation of Cognitive Functions in Parkinson's Disease

Brak IV, Filimonova E, Zakhariya O, Khasanov R, Stepanyan I.

Front Neurosci. 2022 Jul 12;16:781488. doi: 10.3389/fnins.2022.781488. eCollection 2022.

High-dose versus low-dose inhaled levodopa (CVT-301) in patients with Parkinson disease for the treatment of OFF episodes: a meta-analysis of randomized controlled trials

Yan Z, Wang W, Tao X, Cheng W, Zuo G, Chen Z, Wang Z, Chen G.

Neurol Sci. 2022 Nov;43(11):6233-6241. doi: 10.1007/s10072-022-06298-z. Epub 2022 Jul 30.

Unveiling the biopathway for the design of novel COMT inhibitors

Cruz-Vicente P, Gonçalves AM, Barroca-Ferreira J, Silvestre SM, Romão MJ, Queiroz JA, Gallardo E, Passarinha LA.

Drug Discov Today. 2022 Oct;27(10):103328. doi: 10.1016/j.drudis.2022.07.013. Epub 2022 Jul 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias